♪ emily: what do you think about valuations, are we at peak unicorn?: every time you ask a question like that, somewhere, a fairy dies. the unicorn fairy, you have to believe in them. [laughter] steve: i do not know. it is interesting how the private funding world is reaching valuations. at early stage investing, way before the unicorn phase, we are fine if people want to invest in those prices. two companies i am on the board of, we got new offers in unicorn. born everyns being week!" it does not mean anything. the ipo window may be shutting. it seems that way for biotech stocks. emily: i have to ask you, a $10 billion valuation in theranos, do you stand behind them and would you invest again? steve: we stand behind them in the sense that we are in investor. we do not have the answers to the questions swirling around, can i give you an answer to the questions others are asking. i don't have that. here's what i can tell you. i remember meeting her when she was a stanford student, elizabeth holmes, as a teenager started the company with great passion. i